NEW YORK (GenomeWeb) – Synthetic DNA firm Twist Bioscience announced today the completion of a $37 million Series C financing round. 

The round was led by Illumina. New investors Fidelity Management and Research and Foresite Capital Mangement also participated in the round, as did all existing investors including Nick and Joby Pritzker through their family's firm Tao Invest; Arch Invest Venture Partners; Paladin Capital Group; Yuri Milner; and other corporate and venture investors. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.